. . . . . . . . . "\"Danazol capsules should not be administered to patients with: Undiagnosed abnormal genital bleeding. Markedly impaired hepatic, renal, or cardiac function. Pregnancy (see ). WARNINGS Breast feeding. Porphyria - danazol can induce ALA synthetase activity and hence porphyrin metabolism. Androgen-dependent tumor. Active thrombosis or thromboembolic disease and history of such events. Hypersensitivity to danazol.\"" . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "SwZuVGhUMXxd6oJN+Y/nGugGoOhYm861jzCjtx5zxNh34HrWXQKNjzA2TMQnoyAHWOmGJGwxch9KZaJfKGufcBSyBpqAH1GoesocHlUOjr2xw3HV04rgSRcXj0d1L7FmjH62kC0QafBZhsYErVsOK9sltAQXip9rIzryq58lw60=" . . "2021-08-25T13:41:33.029+02:00"^^ . . . . .